Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Slayback Pharma with status To Be Discontinued. The shortage was first posted on 06/05/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Slayback Pharma
- Package NDC
- 71225-126-05
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)
- Initial Posting
- 06/05/2026
- Revised Date